La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Modulation of tyrosine hydroxylase expression by melatonin in human SH-SY5Y neuroblastoma cells

Identifieur interne : 002663 ( Main/Exploration ); précédent : 002662; suivant : 002664

Modulation of tyrosine hydroxylase expression by melatonin in human SH-SY5Y neuroblastoma cells

Auteurs : Catherine R. Mcmillan [Canada] ; Rohita Sharma [Canada] ; Tom Ottenhof [Canada] ; Lennard P. Niles [Canada]

Source :

RBID : Pascal:07-0338042

Descripteurs français

English descriptors

Abstract

We have previously reported in vivo preservation of tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine synthesis, following treatment with physiological doses of melatonin, in a 6-hydroxydopamine model of Parkinson's disease. Based on these findings, we postulated that melatonin would similarly modulate the expression of TH in vitro. Therefore, using human SH-SY5Y neuroblastoma cells which can differentiate into dopaminergic neurons following treatment with retinoic acid, we first examined whether these cells express melatonin receptors. Subsequently, the physiological dose-dependent effects of melatonin on TH expression were examined in both undifferentiated and differentiated cells. The novel detection of the G protein-coupled melatonin MT1 receptor in SH-SY5Y cells by RT-PCR was confirmed by sequencing and Western blotting. In addition, following treatment of SH-SY5Y cells with melatonin (0.1-100 nM) for 24 h, Western analysis revealed a significant increase in TH protein levels. A biphasic response, with significant increases in TH protein at 0.5 and 1 nM melatonin and a reversal at higher doses was seen in undifferentiated cells; whereas in differentiated cells, melatonin was effective at doses of 1 and 100 nM. These findings suggest a physiological role for melatonin in modulating TH expression, possibly via the MT1receptor.


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Modulation of tyrosine hydroxylase expression by melatonin in human SH-SY5Y neuroblastoma cells</title>
<author>
<name sortKey="Mcmillan, Catherine R" sort="Mcmillan, Catherine R" uniqKey="Mcmillan C" first="Catherine R." last="Mcmillan">Catherine R. Mcmillan</name>
<affiliation wicri:level="4">
<inist:fA14 i1="01">
<s1>Department of Psychiatry and Behavioural Neurosciences, McMaster University, HSC-4N77, 1200 Main Street West</s1>
<s2>Hamilton, Ontario, L8N 3Z5</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Hamilton, Ontario, L8N 3Z5</wicri:noRegion>
<orgName type="university">Université McMaster</orgName>
<placeName>
<settlement type="city">Hamilton (Ontario)</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Sharma, Rohita" sort="Sharma, Rohita" uniqKey="Sharma R" first="Rohita" last="Sharma">Rohita Sharma</name>
<affiliation wicri:level="4">
<inist:fA14 i1="01">
<s1>Department of Psychiatry and Behavioural Neurosciences, McMaster University, HSC-4N77, 1200 Main Street West</s1>
<s2>Hamilton, Ontario, L8N 3Z5</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Hamilton, Ontario, L8N 3Z5</wicri:noRegion>
<orgName type="university">Université McMaster</orgName>
<placeName>
<settlement type="city">Hamilton (Ontario)</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ottenhof, Tom" sort="Ottenhof, Tom" uniqKey="Ottenhof T" first="Tom" last="Ottenhof">Tom Ottenhof</name>
<affiliation wicri:level="4">
<inist:fA14 i1="01">
<s1>Department of Psychiatry and Behavioural Neurosciences, McMaster University, HSC-4N77, 1200 Main Street West</s1>
<s2>Hamilton, Ontario, L8N 3Z5</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Hamilton, Ontario, L8N 3Z5</wicri:noRegion>
<orgName type="university">Université McMaster</orgName>
<placeName>
<settlement type="city">Hamilton (Ontario)</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Niles, Lennard P" sort="Niles, Lennard P" uniqKey="Niles L" first="Lennard P." last="Niles">Lennard P. Niles</name>
<affiliation wicri:level="4">
<inist:fA14 i1="01">
<s1>Department of Psychiatry and Behavioural Neurosciences, McMaster University, HSC-4N77, 1200 Main Street West</s1>
<s2>Hamilton, Ontario, L8N 3Z5</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Hamilton, Ontario, L8N 3Z5</wicri:noRegion>
<orgName type="university">Université McMaster</orgName>
<placeName>
<settlement type="city">Hamilton (Ontario)</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">07-0338042</idno>
<date when="2007">2007</date>
<idno type="stanalyst">PASCAL 07-0338042 INIST</idno>
<idno type="RBID">Pascal:07-0338042</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000728</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000592</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000627</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000627</idno>
<idno type="wicri:doubleKey">0304-3940:2007:Mcmillan C:modulation:of:tyrosine</idno>
<idno type="wicri:Area/Main/Merge">002917</idno>
<idno type="wicri:Area/Main/Curation">002663</idno>
<idno type="wicri:Area/Main/Exploration">002663</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Modulation of tyrosine hydroxylase expression by melatonin in human SH-SY5Y neuroblastoma cells</title>
<author>
<name sortKey="Mcmillan, Catherine R" sort="Mcmillan, Catherine R" uniqKey="Mcmillan C" first="Catherine R." last="Mcmillan">Catherine R. Mcmillan</name>
<affiliation wicri:level="4">
<inist:fA14 i1="01">
<s1>Department of Psychiatry and Behavioural Neurosciences, McMaster University, HSC-4N77, 1200 Main Street West</s1>
<s2>Hamilton, Ontario, L8N 3Z5</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Hamilton, Ontario, L8N 3Z5</wicri:noRegion>
<orgName type="university">Université McMaster</orgName>
<placeName>
<settlement type="city">Hamilton (Ontario)</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Sharma, Rohita" sort="Sharma, Rohita" uniqKey="Sharma R" first="Rohita" last="Sharma">Rohita Sharma</name>
<affiliation wicri:level="4">
<inist:fA14 i1="01">
<s1>Department of Psychiatry and Behavioural Neurosciences, McMaster University, HSC-4N77, 1200 Main Street West</s1>
<s2>Hamilton, Ontario, L8N 3Z5</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Hamilton, Ontario, L8N 3Z5</wicri:noRegion>
<orgName type="university">Université McMaster</orgName>
<placeName>
<settlement type="city">Hamilton (Ontario)</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ottenhof, Tom" sort="Ottenhof, Tom" uniqKey="Ottenhof T" first="Tom" last="Ottenhof">Tom Ottenhof</name>
<affiliation wicri:level="4">
<inist:fA14 i1="01">
<s1>Department of Psychiatry and Behavioural Neurosciences, McMaster University, HSC-4N77, 1200 Main Street West</s1>
<s2>Hamilton, Ontario, L8N 3Z5</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Hamilton, Ontario, L8N 3Z5</wicri:noRegion>
<orgName type="university">Université McMaster</orgName>
<placeName>
<settlement type="city">Hamilton (Ontario)</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Niles, Lennard P" sort="Niles, Lennard P" uniqKey="Niles L" first="Lennard P." last="Niles">Lennard P. Niles</name>
<affiliation wicri:level="4">
<inist:fA14 i1="01">
<s1>Department of Psychiatry and Behavioural Neurosciences, McMaster University, HSC-4N77, 1200 Main Street West</s1>
<s2>Hamilton, Ontario, L8N 3Z5</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Hamilton, Ontario, L8N 3Z5</wicri:noRegion>
<orgName type="university">Université McMaster</orgName>
<placeName>
<settlement type="city">Hamilton (Ontario)</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Neuroscience letters</title>
<title level="j" type="abbreviated">Neurosci. lett.</title>
<idno type="ISSN">0304-3940</idno>
<imprint>
<date when="2007">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Neuroscience letters</title>
<title level="j" type="abbreviated">Neurosci. lett.</title>
<idno type="ISSN">0304-3940</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Biological receptor</term>
<term>Cell line</term>
<term>Differentiation</term>
<term>Human</term>
<term>MT1 melatonin receptor</term>
<term>Melatonin</term>
<term>Neuron</term>
<term>Protein</term>
<term>Retinoic acid</term>
<term>Tyrosine 3-monooxygenase</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Tyrosine 3-monooxygenase</term>
<term>Mélatonine</term>
<term>Neurone</term>
<term>Lignée cellulaire</term>
<term>Récepteur mélatonine MT1</term>
<term>Protéine</term>
<term>Récepteur biologique</term>
<term>Différenciation</term>
<term>Rétinoïque acide</term>
<term>Homme</term>
<term>Lignée SHSY5Y</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">We have previously reported in vivo preservation of tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine synthesis, following treatment with physiological doses of melatonin, in a 6-hydroxydopamine model of Parkinson's disease. Based on these findings, we postulated that melatonin would similarly modulate the expression of TH in vitro. Therefore, using human SH-SY5Y neuroblastoma cells which can differentiate into dopaminergic neurons following treatment with retinoic acid, we first examined whether these cells express melatonin receptors. Subsequently, the physiological dose-dependent effects of melatonin on TH expression were examined in both undifferentiated and differentiated cells. The novel detection of the G protein-coupled melatonin MT
<sub>1</sub>
receptor in SH-SY5Y cells by RT-PCR was confirmed by sequencing and Western blotting. In addition, following treatment of SH-SY5Y cells with melatonin (0.1-100 nM) for 24 h, Western analysis revealed a significant increase in TH protein levels. A biphasic response, with significant increases in TH protein at 0.5 and 1 nM melatonin and a reversal at higher doses was seen in undifferentiated cells; whereas in differentiated cells, melatonin was effective at doses of 1 and 100 nM. These findings suggest a physiological role for melatonin in modulating TH expression, possibly via the MT
<sub>1</sub>
receptor.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
<region>
<li>Ontario</li>
</region>
<settlement>
<li>Hamilton (Ontario)</li>
</settlement>
<orgName>
<li>Université McMaster</li>
</orgName>
</list>
<tree>
<country name="Canada">
<region name="Ontario">
<name sortKey="Mcmillan, Catherine R" sort="Mcmillan, Catherine R" uniqKey="Mcmillan C" first="Catherine R." last="Mcmillan">Catherine R. Mcmillan</name>
</region>
<name sortKey="Niles, Lennard P" sort="Niles, Lennard P" uniqKey="Niles L" first="Lennard P." last="Niles">Lennard P. Niles</name>
<name sortKey="Ottenhof, Tom" sort="Ottenhof, Tom" uniqKey="Ottenhof T" first="Tom" last="Ottenhof">Tom Ottenhof</name>
<name sortKey="Sharma, Rohita" sort="Sharma, Rohita" uniqKey="Sharma R" first="Rohita" last="Sharma">Rohita Sharma</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002663 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002663 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:07-0338042
   |texte=   Modulation of tyrosine hydroxylase expression by melatonin in human SH-SY5Y neuroblastoma cells
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022